Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $23.1400 (-1.66%) ($23.0100 - $24.0000) on Tue. Nov. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 87 | Latest Price | $23.1400(-1.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 25.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) ARKK(45%) IBB(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.105% in a week (0% probabilities). VIXM(-33%) VXX(-26%) UNG(-11%) UUP(-9%) TLT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $22.55(2.62%) | 10 Day Moving Average | $20.61(12.28%) | 20 Day Moving Average | $17.33(33.53%) | To recent high | -1.7% | To recent low | 84.4% | Market Cap | $1.719b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |